美圖(01357.HK)售睿晟天和14.86%股權 作價769萬人幣
美圖(01357.HK)公布,向睿晟天和少數股東出售睿晟天和約14.86%股權,作價769萬元人民幣。
另外,倘睿晟天和未能於2022年12月31日前向相關證券監管機構,提交有關睿晟天和股份於中國國內證券交易所上市申請,少數股東將須按與出售代價相同的代價另加每年5%複利,向美圖網售回出售股權,涉及19.81%股權。目前預計截至2020年12月31日止年度集團將不會就出售事項記錄任何損益。
睿晟天和為美圖網擁有約80.19%的非全資子公司。於出售事項完成後,美圖網於睿晟天和的股權將由約80.19%減少至約65.33%,而睿晟天和將繼續為公司的合併聯屬實體,其財務數據於集團財務報表中合併入賬。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.